Allergen-specific immunotherapy and risk of autoimmune disease

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Allergen-specific immunotherapy and risk of autoimmune disease. / Linneberg, Allan; Madsen, Flemming; Skaaby, Tea.

I: Current Opinion in Allergy and Clinical Immunology, Bind 12, Nr. 6, 2012, s. 635-9.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Linneberg, A, Madsen, F & Skaaby, T 2012, 'Allergen-specific immunotherapy and risk of autoimmune disease', Current Opinion in Allergy and Clinical Immunology, bind 12, nr. 6, s. 635-9. https://doi.org/10.1097/ACI.0b013e3283588c8d

APA

Linneberg, A., Madsen, F., & Skaaby, T. (2012). Allergen-specific immunotherapy and risk of autoimmune disease. Current Opinion in Allergy and Clinical Immunology, 12(6), 635-9. https://doi.org/10.1097/ACI.0b013e3283588c8d

Vancouver

Linneberg A, Madsen F, Skaaby T. Allergen-specific immunotherapy and risk of autoimmune disease. Current Opinion in Allergy and Clinical Immunology. 2012;12(6):635-9. https://doi.org/10.1097/ACI.0b013e3283588c8d

Author

Linneberg, Allan ; Madsen, Flemming ; Skaaby, Tea. / Allergen-specific immunotherapy and risk of autoimmune disease. I: Current Opinion in Allergy and Clinical Immunology. 2012 ; Bind 12, Nr. 6. s. 635-9.

Bibtex

@article{e7df6cf2971c4cefb351cf0ea803f431,
title = "Allergen-specific immunotherapy and risk of autoimmune disease",
abstract = "After 100 years of experience with allergen-specific immunotherapy (SIT), an issue that is still unresolved is whether SIT can act as a trigger of, or as a risk factor for, autoimmune disease. We searched the literature for evidence on this topic.",
author = "Allan Linneberg and Flemming Madsen and Tea Skaaby",
year = "2012",
doi = "http://dx.doi.org/10.1097/ACI.0b013e3283588c8d",
language = "English",
volume = "12",
pages = "635--9",
journal = "Current Opinion in Allergy and Clinical Immunology",
issn = "1528-4050",
publisher = "Lippincott Williams & Wilkins",
number = "6",

}

RIS

TY - JOUR

T1 - Allergen-specific immunotherapy and risk of autoimmune disease

AU - Linneberg, Allan

AU - Madsen, Flemming

AU - Skaaby, Tea

PY - 2012

Y1 - 2012

N2 - After 100 years of experience with allergen-specific immunotherapy (SIT), an issue that is still unresolved is whether SIT can act as a trigger of, or as a risk factor for, autoimmune disease. We searched the literature for evidence on this topic.

AB - After 100 years of experience with allergen-specific immunotherapy (SIT), an issue that is still unresolved is whether SIT can act as a trigger of, or as a risk factor for, autoimmune disease. We searched the literature for evidence on this topic.

U2 - http://dx.doi.org/10.1097/ACI.0b013e3283588c8d

DO - http://dx.doi.org/10.1097/ACI.0b013e3283588c8d

M3 - Journal article

VL - 12

SP - 635

EP - 639

JO - Current Opinion in Allergy and Clinical Immunology

JF - Current Opinion in Allergy and Clinical Immunology

SN - 1528-4050

IS - 6

ER -

ID: 48513171